Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks.
Saved in:
| Title: | Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks. |
|---|---|
| Authors: | Rothenberg ML; The University of Texas Health Science Center San Antonio, USA. mace.rothenberg@mcmail.vanderbilt.edu, Kuhn JG, Schaaf LJ, Rodriguez GI, Eckhardt SG, Villalona-Calero MA, Rinaldi DA, Hammond LA, Hodges S, Sharma A, Elfring GL, Petit RG, Locker PK, Miller LL, von Hoff DD |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2001 Nov; Vol. 12 (11), pp. 1631-41. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Print ISSN: 0923-7534 (Print) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
